Literature DB >> 15316624

Pathology and molecular genetics of astrocytic gliomas.

Guido Reifenberger1, Vincent Peter Collins.   

Abstract

Astrocytic gliomas are the most common primary brain tumours. Here we summarize the characteristic neuropathological features of the different types of astrocytic neoplasms according to the World Health Organization classification of tumours of the nervous system. In addition, we report on the present state of the art concerning the molecular genetics of these tumours. Over the past 20 years a number of recurrent chromosomal,genetic and epigenetic alterations have been found to be associated with the different histological types and malignancy grades of astrocytic tumours. However, we are still far from understanding the complex mechanisms that underly tumour initiation and progression in the individual case. Furthermore, the clinical significance of molecular parameters for the diagnostic and prognostic assessment of astrocytic gliomas is still limited. Therefore further investigation of the molecular mechanisms underlying oncogenesis and progression of these most common brain tumours is necessary to improve their diagnostic assessment and to devise novel, individually tailored treatment strategies.

Entities:  

Mesh:

Year:  2004        PMID: 15316624     DOI: 10.1007/s00109-004-0564-x

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  96 in total

1.  Pleomorphic xanthoastrocytoma: what do we really know about it?

Authors:  C Giannini; B W Scheithauer; P C Burger; D J Brat; P C Wollan; B Lach; B P O'Neill
Journal:  Cancer       Date:  1999-05-01       Impact factor: 6.860

Review 2.  The history of cancer epigenetics.

Authors:  Andrew P Feinberg; Benjamin Tycko
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

3.  O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme.

Authors:  Carme Balaña; Jose Luis Ramirez; Miquel Taron; Yannis Roussos; Aurelio Ariza; Rosa Ballester; Carme Sarries; Pedro Mendez; Jose Javier Sanchez; Rafael Rosell
Journal:  Clin Cancer Res       Date:  2003-04       Impact factor: 12.531

4.  Immunophenotype of pleomorphic xanthoastrocytoma.

Authors:  Caterina Giannini; Bernd W Scheithauer; Maria B S Lopes; Takanori Hirose; Johan M Kros; Scott R VandenBerg
Journal:  Am J Surg Pathol       Date:  2002-04       Impact factor: 6.394

5.  Glioblastomas with an oligodendroglial component: a pathological and molecular study.

Authors:  J He; K Mokhtari; M Sanson; Y Marie; M Kujas; S Huguet; P Leuraud; L Capelle; J Y Delattre; J Poirier; K Hoang-Xuan
Journal:  J Neuropathol Exp Neurol       Date:  2001-09       Impact factor: 3.685

6.  Gene amplification as a prognostic factor in primary and secondary high-grade malignant gliomas.

Authors:  E Galanis; J Buckner; D Kimmel; R Jenkins; B Alderete; J O'Fallon; C H Wang; B W Scheithauer; C D James
Journal:  Int J Oncol       Date:  1998-10       Impact factor: 5.650

7.  Frequent epigenetic inactivation of the SLIT2 gene in gliomas.

Authors:  Ashraf Dallol; Dietmar Krex; Luke Hesson; Charis Eng; Eamonn R Maher; Farida Latif
Journal:  Oncogene       Date:  2003-07-17       Impact factor: 9.867

8.  Mouse models of human cancer consortium symposium on nervous system tumors.

Authors:  David H Gutmann; Suzanne J Baker; Marco Giovannini; Joel Garbow; William Weiss
Journal:  Cancer Res       Date:  2003-06-01       Impact factor: 12.701

9.  Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes.

Authors:  E W Newcomb; H Cohen; S R Lee; S K Bhalla; J Bloom; R L Hayes; D C Miller
Journal:  Brain Pathol       Date:  1998-10       Impact factor: 6.508

Review 10.  Using mice to decipher the molecular genetics of brain tumors.

Authors:  Göran Hesselager; Eric C Holland
Journal:  Neurosurgery       Date:  2003-09       Impact factor: 4.654

View more
  64 in total

1.  An NF-κB p65-cIAP2 link is necessary for mediating resistance to TNF-α induced cell death in gliomas.

Authors:  Xueyan Zhao; Travis Laver; Suk W Hong; George B Twitty; Annelies Devos; Marijke Devos; Etty N Benveniste; Susan E Nozell
Journal:  J Neurooncol       Date:  2011-01-30       Impact factor: 4.130

2.  Genome-wide copy number analysis in pediatric glioblastoma multiforme.

Authors:  Laura Giunti; Marilena Pantaleo; Iacopo Sardi; Aldesia Provenzano; Alberto Magi; Stefania Cardellicchio; Francesca Castiglione; Lorenzo Tattini; Francesca Novara; Anna Maria Buccoliero; Maurizio de Martino; Lorenzo Genitori; Orsetta Zuffardi; Sabrina Giglio
Journal:  Am J Cancer Res       Date:  2014-05-26       Impact factor: 6.166

3.  High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalances.

Authors:  Yuri Kotliarov; Mary Ellen Steed; Neil Christopher; Jennifer Walling; Qin Su; Angela Center; John Heiss; Mark Rosenblum; Tom Mikkelsen; Jean C Zenklusen; Howard A Fine
Journal:  Cancer Res       Date:  2006-10-01       Impact factor: 12.701

Review 4.  Spinal cord tumours: advances in genetics and their implications for treatment.

Authors:  Patricia L Zadnik; Ziya L Gokaslan; Peter C Burger; Chetan Bettegowda
Journal:  Nat Rev Neurol       Date:  2013-03-26       Impact factor: 42.937

5.  Pediatric glioblastomas: a histopathological and molecular genetic study.

Authors:  Vaishali Suri; Prasenjit Das; Pankaj Pathak; Ayushi Jain; Mehar Chand Sharma; Sachin Anil Borkar; Ashish Suri; Deepak Gupta; Chitra Sarkar
Journal:  Neuro Oncol       Date:  2008-11-03       Impact factor: 12.300

6.  Comparative expression pattern of Matrix-Metalloproteinases in human glioblastoma cell-lines and primary cultures.

Authors:  Carsten Hagemann; Jelena Anacker; Stefanie Haas; Daniela Riesner; Beate Schömig; Ralf-Ingo Ernestus; Giles H Vince
Journal:  BMC Res Notes       Date:  2010-11-10

7.  The expression level of sphingosine-1-phosphate receptor type 1 is related to MIB-1 labeling index and predicts survival of glioblastoma patients.

Authors:  Yuya Yoshida; Mitsutoshi Nakada; Tomoya Harada; Shingo Tanaka; Takuya Furuta; Yasuhiko Hayashi; Daisuke Kita; Naoyuki Uchiyama; Yutaka Hayashi; Jun-ichiro Hamada
Journal:  J Neurooncol       Date:  2009-11-25       Impact factor: 4.130

8.  Glioblastomas: correlation between oligodendroglial components, genetic abnormalities, and prognosis.

Authors:  Luciana Wernersbach Pinto; Maria Betania Mahler Araújo; Andre L Vettore; Liana Wernersbach; André Campana C Leite; Leila Maria C Chimelli; Fernando Augusto Soares
Journal:  Virchows Arch       Date:  2008-05       Impact factor: 4.064

9.  Heme oxygenase-1 expression in human gliomas and its correlation with poor prognosis in patients with astrocytoma.

Authors:  Norberto A Gandini; María E Fermento; Débora G Salomón; Diego J Obiol; Nancy C Andrés; Jean C Zenklusen; Julián Arevalo; Jorge Blasco; Alejandro López Romero; María M Facchinetti; Alejandro C Curino
Journal:  Tumour Biol       Date:  2014-03

Review 10.  Molecular neuropathology of gliomas.

Authors:  Markus J Riemenschneider; Guido Reifenberger
Journal:  Int J Mol Sci       Date:  2009-01-07       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.